Opportunity ID: 343899

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-22-047
Funding Opportunity Title: Genetic Tools for Understanding Rickettsial and Related Infections (R61/R33 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 03, 2022
Last Updated Date: Oct 03, 2022
Original Closing Date for Applications: Feb 14, 2023
Current Closing Date for Applications: Feb 14, 2023
Archive Date: Mar 22, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Small businesses
City or township governments
Special district governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Private institutions of higher education
County governments
Native American tribal governments (Federally recognized)
Independent school districts
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: A comprehensive understanding of pathogenic bacteriology requires the ability to generate and study genetically altered bacterial strains. For the obligate intracellular human pathogens of the order Rickettsialesincluding Anaplasma, Ehrilichia, Orientia and Rickettsia speciesthese tools have long lagged behind those available for extracellular bacteria. While recent advances have demonstrated the feasibility of genetically manipulating these bacteria, inherent limitations associated with their obligate intracellular nature and reduced genomes have hindered large-scale generation of useful mutants across all species.
This funding opportunity will address that research gap by dedicating support to the generation and functional characterization of mutant libraries for rickettsial species that cause infections in humans, and to the application of these new tools to better understanding the biology of rickettsial pathogens.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-047.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00277120 Jan 14, 2023 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278379 Jan 14, 2023 Feb 14, 2023 View

Package 1

Mandatory forms

343899 RR_SF424_5_0-5.0.pdf

343899 PHS398_CoverPageSupplement_5_0-5.0.pdf

343899 RR_OtherProjectInfo_1_4-1.4.pdf

343899 PerformanceSite_4_0-4.0.pdf

343899 RR_KeyPersonExpanded_4_0-4.0.pdf

343899 RR_Budget_3_0-3.0.pdf

343899 PHS398_ResearchPlan_4_0-4.0.pdf

343899 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343899 RR_SubawardBudget30_3_0-3.0.pdf

343899 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

343899 RR_SF424_5_0-5.0.pdf

343899 PHS398_CoverPageSupplement_5_0-5.0.pdf

343899 RR_OtherProjectInfo_1_4-1.4.pdf

343899 PerformanceSite_4_0-4.0.pdf

343899 RR_KeyPersonExpanded_4_0-4.0.pdf

343899 RR_Budget_3_0-3.0.pdf

343899 PHS398_ResearchPlan_5_0-5.0.pdf

343899 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343899 RR_SubawardBudget30_3_0-3.0.pdf

343899 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T18:20:39-05:00

Share This Post, Choose Your Platform!

About the Author: